Looking forward to this.
AdAlta's (ASX:1AD) CEO and MD, Tim Oldham will host a webinar to discuss AdAlta’s new collaboration with SYNthesis BioVentures under a Memorandum of Understanding announced on Monday 8 April 2024 and general business progress | Register https://us02web.zoom.us/webinar/register/WN_86kBPnJVTja6QmLsty2i7Q#/registration… #1AD #Webinar
Ann: SYNThesis BioVentures MoU for cellular immunotherapies, page-14
Add 1AD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.48M | |||
| Open | High | Low | Value | Volume |
| 2.6¢ | 2.6¢ | 2.5¢ | $19.72K | 760.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1918532 | 2.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.6¢ | 481750 | 1 |
View Market Depth
| Last trade - 12.11pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
2.5¢ |
Change
0.000 ( 3.85 %) |
||||
| Open | High | Low | Volume | ||
| 2.5¢ | 2.5¢ | 2.5¢ | 100000 | ||
| Last updated 10.24am 17/06/2024 ? | |||||
| 1AD (ASX) Chart |
